Editorial: Advancements and challenges in veterinary oncology. [PDF]
Queiroga F +3 more
europepmc +1 more source
Narciclasine triggers apoptosis in osteosarcoma cells via JNK-mediated extrinsic and intrinsic pathways. [PDF]
Yang JS +6 more
europepmc +1 more source
The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis. [PDF]
Yuan K +7 more
europepmc +1 more source
Elevated anti-apoptotic shift in primary human aniridia limbal stromal cells following 48 hours supraphysiological glucose exposure, in vitro. [PDF]
Liu S +10 more
europepmc +1 more source
FH535-mediated inhibition of Wnt/β-catenin suppresses CRC growth and invasion and alters MCP1 and MCP2 expression with potential immunological implications. [PDF]
Janeeh AS +5 more
europepmc +1 more source
Radiolabeling molecular biomarkers of invasive pituitary adenomas: a narrative review. [PDF]
Marche C +6 more
europepmc +1 more source
Effect of folic acid-targeted triptolide-loaded microbubbles combined with ultrasound on apoptosis of human MCF-7 breast cancer xenografts in nude mice. [PDF]
Huang C +7 more
europepmc +1 more source
Survivin can alter mitochondrial architecture by regulating phosphatidylethanolamine synthesis. [PDF]
Dunajová L +5 more
europepmc +1 more source
Related searches:
Survivin is a unique member of the inhibitor-of-apoptosis family. Survivin plays a role in the proliferation and survival of normal hematopoietic cells. Survivin expression is aberrantly enhanced in most cancers and hematopoietic malignancies. Survivin is an attractive therapeutic target, and various approaches to targeting survivin have been tested in
Xiu Li, Cong, Zhong Chao, Han
openaire +2 more sources

